Iambic Therapeutics Stock

Iambic Therapeutics is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

Sign up today and learn more about Iambic Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Iambic Therapeutics Stock

Iambic Therapeutics is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform. Iambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters with strong track records of success in delivering clinically validated therapeutics. The Iambic platform has been demonstrated to deliver high-quality, differentiated therapeutics to clinic with unprecedented speed and across multiple target classes and mechanisms of action. The Iambic team is advancing an internal pipeline of clinical assets to address urgent unmet patient needs. Learn more about the Iambic team, platform, and pipeline at iambic.ai.

Funding History

July 2021$53.0M
October 2023$100M

Management

CEO

Thomas Miller

CTO

Fred Manby

Board Member

Bill Rastetter Rastetter

Board Member

Kurt von Emster

Board Member

Aaron Weiner

Scientific Advisor

Nicholas A. Saccomano

Board Member

Jacob Vogelstein

Board Member

Fred Manby

Board Member

Thomas Miller

Board Member

Naren Gupta

Board Member

Evan Rachlin

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo